Periscope Capital’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-125,000
Closed -$1.49M 250
2025
Q1
$1.49M Hold
125,000
0.64% 59
2024
Q4
$1.46M Sell
125,000
-50,000
-29% -$579K 0.81% 44
2024
Q3
$2.01M Sell
175,000
-275,000
-61% -$3.13M 1.04% 35
2024
Q2
$5.07M Hold
450,000
1.72% 15
2024
Q1
$5M Sell
450,000
-54,301
-11% -$600K 1.26% 20
2023
Q4
$5.52M Buy
504,301
+101,600
+25% +$1.11M 0.93% 32
2023
Q3
$4.36M Hold
402,701
0.49% 62
2023
Q2
$4.3M Hold
402,701
0.33% 99
2023
Q1
$4.22M Hold
402,701
0.2% 175
2022
Q4
$4.13M Buy
402,701
+3,701
+0.9% +$37.5K 0.18% 230
2022
Q3
$4.02M Buy
+399,000
New +$4M 0.12% 340

Other funds holding RENE

Periscope Capital's RENE Position: Q2 2025 in Review

Periscope Capital sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 125,000 shares — an estimated $1.49M sold.

Periscope Capital first reported a position in RENE in Q3 2022 and held it in 11 quarters. The position peaked at $5.52M in Q4 2023. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Periscope Capital reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Periscope Capital sold 125,000 Cartesian Growth Corp II shares in Q2 2025, an estimated $1.49M.
  • Periscope Capital first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 11 quarters.
  • Periscope Capital's Cartesian Growth Corp II position peaked at $5.52M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Periscope Capital's 13F filing for Q2 2025, filed 14 Aug 2025.